Relay Therapeutics, Inc.: accounts_payable
| Value | {"amount": 6316000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2021-09-30) |
| Status | current |
| Entity | Relay Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:14:39.378863+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/58a73be0-5823-4491-b8ef-3af6c45672e2
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-21-056229Retrieved: 2026-08-19T18:14:39.378863+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001812364/accounts-payable/2021-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/58a73be0-5823-4491-b8ef-3af6c45672e2
History
- no predecessors — first report